Alkermes to Report Third Quarter Financial Results on October 28, 2025

Core Points - Alkermes plc will host a conference call and webcast presentation on October 28, 2025, at 8:00 a.m. ET to discuss its third quarter financial results [1] - The conference call can be accessed via specific phone numbers for U.S. and international callers, and a replay will be available on the company's website [2] - Alkermes is a global biopharmaceutical company focused on developing innovative medicines in neuroscience, with a portfolio addressing alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder [2] - The company has a pipeline of clinical and preclinical candidates for neurological disorders, including narcolepsy and idiopathic hypersomnia [2] - Alkermes is headquartered in Ireland, with additional offices in Massachusetts and a manufacturing facility in Ohio [2] Additional Information - Joshua Reed has been appointed as Chief Financial Officer, effective September 15, 2025 [3] - Alkermes has announced the launch of its 8th Annual Alkermes Pathways Research Awards program [4]